REGN Stock Balance Sheets

Regeneron Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Deferred Revenue

Long-Term Debt

Inventory

Regeneron Pharmaceuticals Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30

assets
current assets:
cash and cash equivalents	1,995,800,000	3,090,200,000	2,488,200,000	2,011,800,000	1,920,700,000	2,602,000,000	2,730,000,000	2,152,300,000	1,937,200,000	3,916,300,000	3,105,900,000	3,491,300,000	3,395,100,000	3,345,700,000	2,885,600,000	3,432,400,000	2,072,200,000	1,437,900,000	2,193,700,000	1,573,000,000	1,992,200,000	2,208,200,000	1,617,800,000	1,384,800,000	1,045,500,000	1,708,500,000	1,467,700,000	1,087,843,000	917,876,000	1,019,491,000	812,733,000	792,065,000	744,313,000	811,773,000	535,203,000	920,359,000	646,508,000	604,214,000	809,102,000	654,587,000	390,554,000	507,907,000	648,719,000	646,554,000	600,135,000	461,858,000	535,608,000	263,211,000	381,675,000	180,362,000	230,276,000	118,998,000	171,943,000	394,585,000	206,395,000	254,312,000	135,376,000	112,572,000	325,286,000	112,000,000	117,311,000	207,075,000	250,321,000	271,466,000	247,796,000	314,684,000	292,129,000	520,875,000	97,416,000	109,643,000	156,484,000	237,876,000	167,662,000	114,960,000	182,332,000	184,508,000	176,093,000	145,201,000	147,816,000	101,234,000	105,047,000	122,833,000	174,034,000	118,285,000	298,617,000	129,659,000
marketable securities	5,473,800,000	5,259,200,000	6,524,300,000	7,784,700,000	7,888,300,000	7,917,500,000	8,114,800,000	7,761,300,000	6,990,500,000	5,043,400,000	4,636,400,000	3,530,400,000	4,171,300,000	3,704,900,000	2,809,100,000	2,355,200,000	1,838,600,000	2,065,900,000	1,393,300,000	1,452,900,000	1,152,000,000	1,795,200,000	1,596,500,000	1,493,100,000	1,624,200,000	1,523,900,000	1,342,200,000	1,104,309,000	765,642,000	605,461,000	596,847,000	586,879,000	523,537,000	495,311,000	503,481,000	488,032,000	398,656,000	244,965,000	236,121,000	241,055,000	213,694,000	234,257,000	251,761,000	395,650,000	216,774,000	186,275,000	158,376,000	182,112,000	155,831,000	127,348,000	77,819,000	143,554,000	129,079,000	37,713,000	39,103,000	55,371,000	91,065,000	136,796,000	153,767,000	194,337,000	186,328,000	134,255,000	129,475,000	120,452,000	226,954,000	348,924,000	408,275,000	222,373,000	299,566,000	351,054,000	295,910,000	221,400,000	94,227,000	158,616,000	120,061,000	114,037,000	131,449,000	190,612,000	206,090,000	52,930,000	168,120,000	215,699,000	135,725,000	72,792,000	6,450,000	4,185,000
accounts receivable	5,610,000,000	5,561,000,000	6,211,900,000	6,107,100,000	5,717,100,000	5,222,200,000	5,667,300,000	5,584,500,000	5,121,300,000	5,118,600,000	5,328,700,000	5,548,300,000	5,161,400,000	4,839,000,000	6,036,500,000	5,452,000,000	6,998,600,000	4,173,000,000																																																			10,968,000	20,478,000	33,632,000	7,493,000	7,940,000	12,141,000	11,010,000	36,521,000	10,536,000	16,830,000	10,371,000	43,102,000	24,866,000	25,397,000	59,882,000	15,529,000	9,197,000	7,871,000
inventories	3,205,600,000	3,192,400,000	3,087,300,000	3,018,000,000	2,873,600,000	2,714,900,000	2,580,500,000	2,562,000,000	2,507,700,000	2,424,700,000	2,401,900,000	2,412,200,000	2,218,500,000	1,991,500,000	1,951,300,000	2,053,800,000	1,983,900,000	2,164,700,000	1,916,600,000	1,801,600,000	1,640,900,000	1,480,900,000	1,415,500,000	1,344,300,000	1,317,200,000	1,208,800,000	1,151,200,000	1,039,679,000	928,553,000	820,397,000	726,138,000	641,588,000	554,320,000	466,576,000	399,356,000	345,620,000	316,073,000	303,294,000	238,578,000	190,668,000	171,266,000	133,863,000	128,861,000	120,317,000	109,897,000	86,545,000	70,354,000
prepaid expenses and other current assets	574,300,000	468,900,000	349,200,000	412,000,000	681,900,000	414,900,000	386,600,000	574,700,000	366,300,000	406,200,000	411,200,000	446,400,000	583,600,000	424,900,000	332,400,000	482,000,000	444,300,000	213,600,000	160,800,000	230,600,000	263,800,000	226,600,000	387,100,000	226,900,000	208,200,000	182,200,000	243,300,000	284,807,000	163,599,000	155,451,000	224,972,000	143,761,000	193,334,000	146,055,000	130,528,000	103,806,000	96,017,000	115,685,000	163,501,000	89,494,000	43,099,000	34,099,000	71,486,000	61,732,000	60,674,000	52,252,000	96,141,000	156,839,000	108,913,000	97,142,000	56,663,000	84,780,000	32,791,000	26,270,000	15,927,000	19,026,000	10,904,000	15,142,000	14,379,000	16,217,000	19,947,000	18,610,000	14,032,000	13,068,000	11,480,000	9,726,000	9,151,000	11,297,000	14,070,000	15,806,000	3,137,000	3,215,000	3,920,000	3,211,000	2,990,000	3,422,000	4,043,000	2,923,000	2,490,000	1,642,000	3,391,000	3,033,000	2,568,000	1,898,000	2,810,000	3,063,000
total current assets	16,859,500,000	17,571,700,000	18,660,900,000	19,333,600,000	19,081,600,000	18,871,500,000	19,479,200,000	18,634,800,000	16,923,000,000	16,909,200,000	15,884,100,000	15,428,600,000	15,529,900,000	14,306,000,000	14,014,900,000	13,775,400,000	13,337,600,000	10,055,100,000	9,779,100,000	9,097,600,000	7,860,200,000	8,644,100,000	7,689,100,000	7,109,100,000	6,651,000,000	6,928,600,000	6,447,600,000	5,719,583,000	4,814,917,000	4,544,732,000	4,335,030,000	4,135,742,000	3,860,051,000	3,669,263,000	3,180,188,000	3,501,689,000	3,209,225,000	3,133,379,000	2,915,095,000	2,675,640,000	2,283,341,000	2,310,714,000	2,167,461,000	2,200,512,000	1,918,695,000	1,871,049,000	1,796,934,000	1,634,160,000	1,561,362,000	1,307,122,000	1,206,012,000	948,603,000	769,193,000	696,915,000	339,872,000	413,273,000	325,501,000	357,622,000	575,719,000	417,750,000	395,444,000	425,508,000	461,594,000	465,032,000	521,442,000	715,540,000	742,393,000	787,505,000	422,020,000	496,981,000	489,163,000	469,984,000	273,749,000	291,056,000	319,647,000	341,392,000	324,958,000	359,312,000	369,854,000		311,238,000	383,330,000	392,284,000
property, plant, and equipment	4,840,700,000	4,694,200,000	4,599,700,000	4,439,200,000	4,305,900,000	4,225,500,000	4,146,400,000	4,006,100,000	3,922,600,000	3,880,900,000	3,763,000,000	3,704,200,000	3,637,700,000	3,556,400,000	3,482,200,000	3,395,700,000	3,358,500,000	3,262,600,000	3,221,600,000	3,138,300,000	3,031,400,000	2,944,600,000	2,890,400,000	2,771,400,000	2,676,600,000	2,612,800,000	2,575,800,000	2,524,446,000	2,461,614,000	2,394,727,000	2,358,605,000	2,274,529,000	2,261,702,000	2,277,029,000	2,083,421,000	1,872,167,000	1,772,923,000	1,666,391,000
intangible assets	1,351,700,000	1,167,000,000	1,148,600,000	1,120,100,000	1,102,200,000	1,058,700,000	1,038,600,000	1,017,200,000	953,000,000	928,700,000	915,500,000	804,100,000
deferred tax assets	3,572,200,000	3,442,900,000	3,314,100,000	3,015,100,000	2,880,900,000	2,764,900,000	2,575,400,000	2,316,800,000	2,138,500,000	1,924,900,000	1,723,700,000	1,452,100,000	1,352,400,000	1,140,300,000	876,900,000	723,200,000	746,600,000	765,100,000	858,900,000	804,200,000	774,000,000	771,200,000	824,200,000	808,300,000	821,600,000	829,300,000	828,700,000	562,818,000	545,077,000	532,268,000	506,291,000	927,023,000	882,980,000	866,291,000	825,303,000	655,552,000	626,191,000	543,689,000	461,945,000	60,521,000	69,603,000	62,126,000	49,235,000	49,005,000	37,291,000	36,623,000	44,677,000	39,174,000	38,927,000	99,632,000	148,134,000
other noncurrent assets	1,536,900,000	1,393,100,000	1,136,000,000	1,043,000,000	993,800,000	470,200,000	444,100,000	409,900,000	393,200,000	349,600,000	336,400,000	320,200,000	269,900,000	262,000,000	222,800,000	145,900,000	142,900,000	145,700,000	168,100,000	168,800,000	175,500,000	161,200,000	144,700,000	137,900,000	139,800,000	144,300,000	127,400,000	125,197,000	85,669,000	78,984,000
total assets	38,219,200,000	37,545,200,000	37,759,400,000	37,441,900,000	36,086,800,000	34,369,600,000	33,080,200,000	32,163,300,000	30,657,500,000	30,059,900,000	29,214,500,000	27,677,800,000	27,205,800,000	26,348,700,000	25,434,800,000	23,671,500,000	21,485,900,000	17,772,200,000	17,163,300,000	16,084,000,000	14,428,700,000	15,757,500,000	14,805,200,000	13,939,300,000	13,173,600,000	12,854,800,000	11,734,500,000	10,805,613,000	9,951,980,000	9,372,696,000	8,764,286,000	8,701,215,000	8,106,373,000	7,817,365,000	6,973,466,000	6,828,019,000	6,204,906,000	5,904,460,000	5,609,132,000	5,182,915,000	4,526,970,000	4,198,573,000	3,871,827,000	3,739,419,000	3,456,078,000	3,260,396,000	2,951,013,000	2,640,415,000	2,378,259,000	2,275,998,000	2,080,490,000	1,660,615,000	1,457,500,000	1,350,159,000	983,031,000	1,046,864,000	1,074,293,000	1,089,432,000	942,433,000	790,641,000	787,156,000	741,202,000	742,192,000	742,345,000	670,038,000	825,891,000	851,225,000	930,876,000	573,096,000	597,858,000	601,431,000	585,090,000	355,186,000	378,332,000	402,089,000	423,501,000	419,275,000	446,948,000	470,292,000		472,685,000	488,174,000	506,178,000
liabilities and stockholders' equity
current liabilities:
accounts payable	723,900,000	705,500,000	789,500,000	497,300,000	561,700,000	671,300,000	606,600,000	536,600,000	547,300,000	599,500,000	589,200,000	535,600,000	534,200,000	470,300,000	564,000,000	427,000,000	476,000,000	542,900,000	475,500,000	443,100,000	380,100,000	347,800,000	418,100,000	335,600,000	244,000,000	239,600,000	218,200,000	172,361,000	171,906,000	207,611,000
accrued expenses and other current liabilities	2,461,200,000	2,241,800,000	2,527,100,000	2,536,500,000	2,360,900,000	2,392,900,000	2,357,900,000	2,644,700,000	2,176,000,000	2,074,300,000	2,074,200,000	1,796,400,000	1,933,400,000	2,046,000,000	2,206,800,000	2,061,000,000	2,018,000,000	1,492,200,000	1,521,800,000	1,303,000,000	1,257,000,000	1,143,200,000	1,086,800,000	821,100,000	876,700,000	741,100,000	772,100,000	781,924,000	670,709,000	666,216,000
deferred revenue	481,900,000	619,300,000	627,700,000	627,200,000	586,000,000	516,700,000	458,900,000	417,300,000	381,100,000	426,300,000	477,900,000	547,200,000	566,300,000	491,300,000	442,000,000	507,800,000	520,000,000	464,900,000																																																			125,013,000	113,691,000	121,138,000	123,452,000	60,015,000	63,057,000	66,099,000	69,142,000	49,373,000	51,939,000	54,577,000	56,426,000	57,876,000	60,598,000	65,621,000	68,830,000	89,563,000	3,493,000
total current liabilities	3,667,000,000	3,566,600,000	3,944,300,000	3,661,000,000	3,508,600,000	3,580,900,000	3,423,400,000	3,598,600,000	3,104,400,000	3,100,100,000	3,141,300,000	2,879,200,000	3,033,900,000	3,007,600,000	3,932,500,000	3,714,800,000	3,732,400,000	3,217,800,000	2,697,400,000	2,337,800,000	3,702,400,000	2,055,200,000	2,096,600,000	1,765,400,000	1,713,100,000	1,511,400,000	1,442,800,000	1,417,230,000	1,331,190,000	1,265,740,000	1,135,483,000	1,138,628,000	1,029,017,000	1,308,271,000	1,241,495,000	961,185,000	951,563,000	919,724,000	811,162,000	734,990,000	601,542,000	536,134,000	654,660,000	410,200,000	351,578,000	305,068,000	298,835,000	268,727,000	203,802,000	197,244,000	163,550,000	178,568,000	183,220,000	160,386,000	133,235,000	135,868,000	112,252,000	109,056,000	133,833,000	119,571,000	104,093,000	93,575,000	114,165,000	120,424,000	83,672,000	217,771,000	223,918,000	285,954,000	96,686,000	104,831,000	83,604,000	45,014,000	32,698,000	31,508,000	33,667,000	40,357,000	33,521,000	29,949,000	29,931,000		35,900,000	37,372,000	36,335,000
long-term debt	1,985,100,000	1,984,800,000	1,984,400,000	1,984,000,000	1,983,600,000	1,983,300,000	1,982,900,000	1,982,600,000	1,982,200,000	1,981,800,000	1,981,400,000	1,981,100,000	1,980,700,000	1,980,400,000	1,980,000,000	1,979,600,000	1,979,200,000	1,978,900,000	1,978,500,000	1,978,300,000
finance lease liabilities	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000	720,000,000					719,700,000	719,000,000	718,400,000	717,800,000	717,200,000	716,500,000	715,900,000	715,200,000	713,900,000	712,700,000	711,300,000	709,900,000
other noncurrent liabilities	1,701,900,000	1,674,400,000	1,571,400,000	1,543,600,000	1,463,200,000	908,500,000	854,100,000	832,400,000	716,800,000	677,300,000	638,000,000	598,600,000	724,700,000	692,500,000	680,200,000	662,600,000	596,300,000	571,500,000	497,800,000	454,000,000	457,900,000	321,500,000	286,000,000	273,000,000	267,900,000	376,300,000	361,700,000	194,033,000	190,020,000	169,922,000
total liabilities	8,280,300,000	8,157,600,000	8,405,800,000	8,116,000,000	7,881,000,000	7,378,500,000	7,107,100,000	7,258,900,000	6,639,600,000	6,564,700,000	6,550,500,000	6,239,000,000	6,518,000,000	6,434,000,000	6,666,000,000	6,413,500,000	6,358,600,000	5,795,200,000	6,138,000,000	5,958,500,000	5,371,300,000	3,624,500,000	3,715,500,000	3,434,900,000	3,417,700,000	3,410,100,000	2,977,200,000	2,937,313,000	2,765,554,000	2,805,052,000	2,620,208,000	2,649,622,000	2,585,635,000	2,951,344,000	2,524,221,000	2,336,772,000	2,128,400,000	2,139,378,000	1,954,295,000	1,886,048,000	1,188,512,000	1,227,143,000	1,329,502,000	1,187,631,000	1,087,236,000	1,049,148,000	998,937,000	950,244,000	884,922,000	869,650,000	835,105,000	854,591,000	862,843,000	846,135,000	554,778,000	568,830,000	556,202,000	561,617,000	594,369,000	419,425,000	400,885,000	344,440,000	319,749,000	331,839,000	251,186,000	388,958,000	400,228,000	470,273,000	421,699,000	418,522,000	404,742,000	368,466,000	292,713,000	294,565,000	299,766,000	309,499,000	282,894,000	281,888,000	284,508,000		293,812,000	298,044,000	302,072,000
stockholders' equity:
preferred stock, par value .01 per share; 30.0 shares authorized; shares issued and outstanding - none
class a stock, convertible, par value .001 per share; 40.0 shares authorized; shares issued and outstanding - 1.8 in 2025 and 2024
common stock	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	110,000	110,000	110,000	110,000	109,000	109,000	108,000	108,000	107,000	107,000	107,000	106,000	106,000	105,000	103,000	102,000	100,000	100,000	99,000	97,000	97,000	97,000	95,000	95,000	94,000														77,000	77,000	77,000	64,000	64,000	63,000		55,000	55,000		54,000	54,000	54,000				53,000	53,000
additional paid-in capital	13,490,800,000	13,192,100,000	12,855,900,000	12,702,800,000	12,316,900,000	11,942,600,000	11,354,000,000	11,251,500,000	10,888,500,000	10,597,700,000	9,949,300,000	9,518,200,000	9,120,200,000	8,754,100,000	8,087,500,000	7,919,300,000	7,225,800,000	6,887,800,000	6,716,200,000	6,592,800,000	6,263,000,000	5,211,400,000	4,428,600,000	4,388,400,000	4,263,600,000	4,160,900,000	3,911,600,000	3,841,174,000	3,712,599,000	3,611,599,000	3,512,833,000	3,570,673,000	3,449,622,000	3,190,882,000	3,029,993,000	3,314,982,000	3,156,942,000	3,049,651,000	3,099,526,000	2,880,109,000	3,118,969,000	2,812,573,000	2,404,118,000	2,423,434,000	2,342,839,000	2,236,931,000	2,045,857,000	1,882,421,000	1,827,471,000	1,826,075,000	1,763,508,000	1,795,293,000	1,775,861,000	1,760,938,000	1,643,772,000	1,630,362,000	1,609,185,000	1,575,780,000	1,379,123,000	1,368,531,000	1,357,089,000	1,336,732,000	1,323,432,000	1,313,003,000	1,294,813,000	1,285,223,000	1,274,527,000	1,264,531,000	931,482,000	924,094,000	914,317,000	904,407,000	719,157,000	713,419,000	708,297,000	700,011,000	693,426,000	687,965,000	682,578,000	675,389,000	673,635,000	674,505,000	674,242,000	673,118,000	670,120,000	622,931,000
retained earnings	33,680,200,000	32,384,400,000	31,672,900,000	30,755,200,000	29,414,600,000	27,982,300,000	27,260,300,000	26,100,700,000	25,092,900,000	24,124,500,000	23,306,700,000	22,109,600,000	20,793,900,000	19,941,800,000	18,968,300,000	16,739,300,000	15,107,100,000	12,008,200,000	10,893,000,000	9,743,800,000	8,901,700,000	8,004,400,000	7,379,800,000	6,587,800,000	5,918,200,000	5,725,100,000	5,254,300,000	4,433,904,000	3,839,179,000	3,287,767,000	2,946,733,000	2,773,214,000	2,384,897,000	1,997,153,000	1,748,222,000	1,495,107,000	1,230,303,000	1,018,436,000	852,700,000	697,706,000	487,308,000	292,665,000	255,382,000	145,206,000	65,486,000
accumulated other comprehensive income	52,500,000	29,100,000		60,200,000											-26,200,000	9,500,000	15,700,000	16,200,000	29,300,000	30,800,000	35,500,000	-9,100,000	21,100,000	16,500,000	15,800,000	2,800,000	-12,300,000	-10,519,000	-11,612,000	-15,594,000	640,000	23,835,000	2,348,000		-12,840,000	-2,899,000	5,204,000	4,364,000	8,572,000	7,721,000	19,153,000	47,904,000	52,251,000	26,895,000	4,263,000	1,465,000												-2,491,000	-175,000	-306,000	717,000	1,044,000	3,537,000	1,014,000	-114,000	-3,960,000	-315,000	828,000												-769,000	-202,000	-211,000	173,000	104,000	56,000	224,000
treasury stock	-17,284,700,000	-16,218,100,000	-15,167,400,000	-14,192,400,000	-13,455,900,000	-12,856,700,000	-12,560,400,000	-12,271,100,000	-11,765,900,000	-11,045,500,000	-10,353,300,000	-9,914,000,000	-9,002,600,000	-8,611,200,000	-8,260,900,000	-7,410,200,000	-7,221,400,000	-6,935,300,000	-6,613,300,000	-6,242,000,000	-6,142,900,000	-1,073,800,000	-739,900,000	-488,400,000	-441,800,000	-444,200,000	-396,400,000	-396,371,000	-353,852,000	-316,240,000	-316,240,000	-316,240,000	-316,240,000	-316,240,000	-316,240,000	-316,052,000	-316,052,000	-307,478,000	-306,069,000	-288,777,000	-287,079,000	-181,817,000	-169,530,000	-43,849,000	-43,848,000
total stockholders' equity	29,938,900,000	29,387,600,000	29,353,600,000	29,325,900,000	28,205,800,000	26,991,100,000	25,973,100,000	24,904,400,000	24,017,900,000	23,495,200,000	22,664,000,000	21,438,800,000	20,687,800,000	19,914,700,000	18,768,800,000	17,258,000,000	15,127,300,000	11,977,000,000	11,025,300,000	10,125,500,000	9,057,400,000	12,133,000,000	11,089,700,000	10,504,400,000	9,755,900,000	9,444,700,000	8,757,300,000	7,868,300,000	7,186,426,000	6,567,644,000	6,144,078,000	6,051,593,000	5,520,738,000	4,866,021,000	4,449,245,000	4,491,247,000	4,076,506,000	3,765,082,000	3,654,837,000	3,296,867,000	3,338,458,000	2,971,430,000	2,542,325,000	2,551,788,000	2,368,842,000	2,211,248,000	1,952,076,000	1,690,171,000	1,493,337,000	1,406,348,000	1,245,385,000	806,024,000	594,657,000	504,024,000	428,253,000	478,034,000	518,091,000		348,064,000	371,216,000	386,271,000		422,443,000	410,506,000
total liabilities and stockholders' equity	38,219,200,000	37,545,200,000	37,759,400,000	37,441,900,000	36,086,800,000	34,369,600,000	33,080,200,000	32,163,300,000	30,657,500,000	30,059,900,000	29,214,500,000	27,677,800,000	27,205,800,000	26,348,700,000	25,434,800,000	23,671,500,000	21,485,900,000	17,772,200,000	17,163,300,000	16,084,000,000	14,428,700,000	15,757,500,000	14,805,200,000	13,939,300,000	13,173,600,000	12,854,800,000	11,734,500,000	10,805,613,000	9,951,980,000	9,372,696,000	8,764,286,000	8,701,215,000	8,106,373,000	7,817,365,000	6,973,466,000	6,828,019,000	6,204,906,000	5,904,460,000	5,609,132,000	5,182,915,000	4,526,970,000	4,198,573,000	3,871,827,000	3,739,419,000	3,456,078,000	3,260,396,000	2,951,013,000	2,640,415,000	2,378,259,000	2,275,998,000	2,080,490,000	1,660,615,000	1,457,500,000	1,350,159,000	983,031,000	1,046,864,000	1,074,293,000		942,433,000	790,641,000	787,156,000		742,192,000	742,345,000
the accompanying notes are an integral part of the financial statements.
commitments and contingencies
class a stock, convertible, par value .001 per share; 40.0 shares authorized; shares issued and outstanding - 1.8 in 2024 and 2023
accumulated other comprehensive loss			-7,900,000		-69,900,000	-77,200,000	-80,900,000	-176,800,000	-197,700,000	-181,600,000	-238,800,000	-275,100,000	-223,800,000	-170,100,000																				-5,884,000													-1,188,000	-2,851,000	-3,429,000	-1,644,000	-1,166,000	-1,904,000	-2,371,000	-1,337,000	-1,731,000	-904,000	-2,175,000												-5,000	-516,000	-159,000	-231,000	-95,000	-473,000	-371,000	-470,000	-682,000	-709,000	-1,110,000
class a stock, convertible, par value .001 per share; 40.0 shares authorized; shares issued and outstanding - 1.8 in 2023 and 2022
preferred stock, par value .01 per share; 30.0 shares authorized; issued and outstanding - none
class a stock, convertible, par value .001 per share; 40.0 shares authorized; shares issued and outstanding - 1.8 in 2022 and 2021
preferred stock, .01 par value; 30,000,000 shares authorized; issued and outstanding - none
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,823,823 in 2022 and 2021
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,823,283 in 2021 and 1,848,970 in 2020
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,848,970 in 2021 and 2020
accounts receivable - trade																			3,111,500,000	3,092,500,000	1,991,000,000	2,063,100,000	2,100,000,000	2,027,700,000	1,920,200,000	1,728,400,000	1,723,700,000	1,665,737,000	1,534,324,000	1,531,936,000	1,538,642,000	1,532,693,000	1,420,403,000	1,339,794,000	1,343,368,000	1,332,071,000	1,431,966,000	1,450,572,000	1,152,489,000	1,088,207,000	1,071,665,000	1,015,962,000	739,379,000	673,915,000	664,075,000	801,773,000	787,071,000	855,844,000	767,865,000	703,857,000	593,207,000	506,682,000	349,645,000	159,462,000
accounts receivable - sanofi																			404,700,000	460,800,000	389,200,000	468,300,000
accounts receivable - other																			598,500,000	486,200,000	431,100,000	401,800,000																																	3,659,000	2,921,000	3,765,000	13,509,000	3,048,000	4,070,000	3,020,000	2,865,000	3,813,000	5,806,000	1,910,000
deferred revenue - sanofi																			341,700,000	409,300,000	380,200,000	398,000,000
deferred revenue - other																			236,000,000	85,500,000	81,300,000	81,200,000	196,200,000	181,600,000	168,100,000	196,600,000	205,800,000	216,133,000	180,396,000	160,466,000	249,263,000	274,666,000	295,621,000	316,227,000	327,298,000	327,868,000	146,449,000	170,658,000	82,015,000	78,942,000	76,748,000	114,318,000	103,909,000	114,339,000	128,042,000	128,539,000	107,677,000	111,893,000	119,672,000	125,436,000	131,822,000	141,132,000	149,031,000	154,929,000	166,623,000	174,987,000	183,019,000	188,775,000	197,139,000	42,009,000	44,504,000	46,951,000	49,421,000	51,893,000	56,835,000
other liabilities - sanofi																			122,400,000	96,900,000	103,800,000	85,000,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,848,970 in 2020 and 2019
debt																					1,500,000,000
accounts receivable from sanofi																							260,600,000	345,400,000	252,000,000	287,600,000	226,400,000	269,271,000	243,238,000	168,855,000	193,684,000	217,478,000	221,078,000	214,269,000	92,989,000	124,107,000	138,067,000	173,782,000	153,152,000	199,117,000	197,693,000	159,444,000	121,058,000	110,720,000	116,865,000	118,003,000	104,707,000	136,980,000	108,151,000	98,781,000	99,913,000	94,589,000	85,735,000	78,885,000	74,788,000	81,643,000
accounts receivable from bayer																							311,600,000	286,900,000	283,700,000	289,200,000	293,100,000	267,937,000	261,685,000	243,141,000	242,014,000	221,278,000	203,066,000	195,485,000	175,263,000	187,694,000	181,938,000	240,867,000
deferred revenue from sanofi																							395,500,000	427,100,000	424,300,000	334,100,000	246,700,000	246,812,000	308,179,000	231,447,000	379,936,000	408,786,000	443,904,000	520,191,000	503,474,000	529,791,000	549,342,000	565,773,000	582,664,000	599,339,000	46,095,000	48,656,000	72,367,000	75,283,000	75,862,000	73,694,000	76,522,000	77,670,000	78,740,000	76,909,000	76,520,000	77,446,000	78,281,000	83,625,000	88,033,000	91,712,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,848,970 in 2019 and 1,911,354 in 2018
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,911,354 in 2019 and 2018
capital and facility lease obligations																											708,500,000	707,203,000	705,903,000	704,645,000				7,200,000
preferred stock, .01 par value; 30,0000,000 shares authorized; issued and outstanding - none
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,911,354 in 2018 and 2017																												2,000	2,000	2,000
other assets																															77,866,000	36,618,000	36,963,000	37,087,000	20,294,000	20,705,000	6,715,000	5,791,000	5,810,000	4,583,000	4,138,000	4,473,000	3,034,000	3,416,000	8,877,000	5,340,000	5,327,000	4,409,000	15,211,000	20,078,000	23,100,000	18,322,000	19,567,000	20,393,000	13,023,000	12,287,000	10,228,000	6,789,000	6,860,000	6,697,000	7,213,000	7,338,000	6,629,000	7,460,000	8,032,000	8,273,000	512,000	342,000	1,408,000	1,645,000	1,906,000	2,170,000	2,694,000	2,915,000	3,185,000	3,465,000	4,253,000	4,472,000	4,761,000	4,984,000	5,036,000	5,235,000	5,636,000	5,833,000	5,958,000	6,223,000
accounts payable and accrued expenses																															815,078,000	818,426,000	716,364,000	1,061,777,000	879,096,000	714,916,000	759,643,000	733,276,000	644,112,000	577,428,000	529,505,000	462,762,000	484,228,000	337,976,000	283,385,000	237,935,000	250,896,000	219,138,000	153,826,000	145,413,000	111,345,000	124,224,000	126,768,000	106,723,000	78,890,000	81,665,000	58,602,000	53,658,000	74,976,000	58,256,000	53,905,000	49,031,000	55,291,000	51,881,000	36,168,000	41,887,000	38,289,000	30,314,000	27,872,000	34,905,000	20,081,000	21,471,000	19,054,000	16,466,000	18,383,000	23,337,000	20,599,000	17,043,000	17,468,000	18,872,000	20,284,000	15,743,000	18,947,000	18,933,000	20,967,000	14,043,000
deferred revenue from sanofi, current portion																															177,746,000	187,036,000	184,452,000	112,161,000	115,267,000	105,041,000	104,141,000	99,314,000	101,573,000	100,908,000	18,026,000	19,342,000	15,927,000	13,368,000	12,979,000	12,980,000	12,815,000	13,866,000	14,916,000	15,967,000	17,022,000	19,588,000	21,790,000	20,141,000	19,819,000	19,720,000
deferred revenue - other, current portion																															142,392,000	132,832,000	127,804,000	126,257,000	116,397,000	137,642,000	84,084,000	73,626,000	51,914,000	54,148,000	51,720,000	51,845,000	58,098,000	57,604,000	54,154,000	53,093,000	34,185,000	34,929,000	34,266,000	34,391,000	33,809,000	33,479,000	33,479,000	32,429,000	33,606,000	33,606,000	33,291,000	35,217,000	38,888,000	41,741,000	31,969,000	27,021,000	37,294,000	46,990,000	26,114,000
other current liabilities																															267,000	334,000	397,000	876,000	3,461,000	3,586,000	3,695,000	13,508,000	13,563,000	2,506,000	2,291,000	2,185,000	96,407,000
other long-term liabilities																															152,073,000	125,225,000	115,920,000	106,248,000	100,385,000	135,700,000	119,523,000	120,993,000	115,535,000	77,910,000	76,080,000	55,559,000	40,855,000	23,747,000	14,968,000	11,794,000	11,330,000	10,573,000															3,341,000																		36,000	74,000	116,000	159,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,911,354 in 2017 and 1,911,456 in 2016																															2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,911,456 in 2017 and 2016																																2,000	2,000	2,000
capital lease obligations																																			127,274,000
facility lease obligations																																			351,569,000	382,228,000	361,523,000	362,230,000	362,919,000	364,144,000	357,687,000	328,394,000	310,938,000	276,112,000	234,525,000	203,380,000	184,258,000	167,219,000	164,392,000	159,007,000	159,436,000	159,499,000	159,558,000	159,534,000	159,482,000	159,457,000	159,353,000	159,355,000	158,382,000	157,359,000	156,464,000	109,022,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,911,456 in 2016 and 1,913,776 in 2015																																			2,000	2,000	2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,913,136 in 2016 and 1,913,776 in 2015																																						2,000
accounts receivable from bayer healthcare																																							162,152,000	151,991,000	125,767,000	163,056,000	156,962,000	142,619,000	112,984,000	127,720,000
property, plant, and equipment, at cost, net of accumulated depreciation and amortization																																							1,594,120,000	1,475,123,000	1,326,112,000	1,110,597,000	974,309,000	818,967,000	707,321,000	600,864,000	526,983,000	453,891,000	419,651,000	392,378,000	379,940,000	372,917,000														72,825,000	64,231,000	58,419,000	49,358,000	47,647,000	47,781,000	49,353,000	51,035,000	53,854,000	57,421,000	60,535,000	64,044,000	67,366,000	69,055,000	71,239,000	73,942,000	75,986,000	77,616,000	80,723,000	83,715,000	84,670,000
convertible senior notes																																								30,723,000	30,360,000	144,082,000	146,773,000	287,950,000	282,261,000	326,673,000	320,315,000	314,162,000	308,116,000	302,268,000	296,518,000	290,959,000	285,491,000	280,206,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,913,776 in 2015 and 1,973,368 in 2014																																							2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,914,776 in 2015 and 1,973,368 in 2014																																								2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,951,868 in 2015 and 1,973,368 in 2014																																									2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,971,868 in 2015 and 1,973,368 in 2014																																										2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,973,368 in 2014 and 2,020,481 in 2013																																											2,000	2,000
facility lease obligations, current portion																																												1,252,000	1,060,000	1,060,000	939,000	794,000	794,000	1,473,000	1,374,000	1,277,000	1,183,000	1,093,000	920,000	877,000	798,000	675,000	634,000	448,000	435,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 1,998,785 in 2014 and 2,020,481 in 2013																																													2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,000,781 at march 31, 2014 and 2,020,481 at december 31, 2013																																														2,000
accumulated deficit																																														-27,249,000	-92,692,000	-189,498,000	-330,804,000	-418,180,000	-517,054,000	-987,461,000	-1,178,929,000	-1,255,672,000	-1,213,880,000	-1,151,515,000	-1,089,010,000	-1,045,563,000	-1,030,966,000	-997,091,000	-971,617,000	-941,095,000	-904,606,000	-903,591,000	-875,927,000	-844,409,000	-823,294,000	-804,835,000	-780,146,000	-744,308,000	-717,534,000	-687,617,000	-656,646,000	-629,236,000	-605,660,000	-585,280,000	-555,608,000	-520,956,000	-493,957,000	-489,834,000	-492,626,000	-481,550,000	-467,001,000	-531,533,000	-512,156,000	-482,921,000
restricted cash and marketable securities																																																		8,494,000	8,186,000	8,173,000	8,141,000	8,154,000	8,150,000	8,165,000	7,520,000	7,518,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,020,481 at december 31, 2013 and 2,069,187 at december 31, 2012																																															2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,028,871 at september 30, 2013 and 2,069,187 at december 31, 2012																																																2,000
other long term liabilities																																																	10,200,000	8,786,000	7,259,000	6,987,000	7,262,000	7,455,000	7,405,000	6,806,000	7,180,000	7,350,000	5,289,000	4,318,000	4,140,000	3,959,000		1,235,000	5,093,000	2,885,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,038,920 at june 30, 2013 and 2,069,187 at december 31, 2012																																																	2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,058,057 at march 31, 2013 and 2,069,187 at december 31, 2012																																																		2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,069,187 at december 31, 2012 and 2,109,512 at december 31, 2011																																																			2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,089,512 at september 30, 2012 and 2,109,512 at december 31, 2011																																																				2,000
property, plant, and equipment, at cost, net of accumulated
depreciation and amortization																																																					372,278,000	369,959,000	363,913,000	361,883,000	357,423,000	347,450,000	318,498,000	292,329,000	274,621,000	259,676,000	215,169,000	195,408,000	87,853,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized;
shares issued and outstanding - 2,089,512 at june 30, 2012 and 2,109,512 at december 31, 2011																																																					2,000
shares issued and outstanding - 93,941,788 at june 30, 2012 and 90,692,071 at december 31, 2011																																																					94,000
shares issued and outstanding - 2,089,512 at march 31, 2012 and 2,109,512 at december 31, 2011																																																						2,000
shares issued and outstanding - 92,969,427 at march 31, 2012 and 90,692,071 at december 31, 2011																																																						93,000
current assets
current liabilities
stockholders' equity
preferred stock, .01 par value; 30,000,000 shares authorized; issued and
outstanding - none
shares issued and outstanding - 2,109,512 in 2011 and 2,182,036 in 2010																																																							2,000
shares issued and outstanding - 90,418,871 in 2011 and 87,238,301 in 2010																																																							90,000
shares issued and outstanding - 2,126,717 in 2011 and 2,182,036 in 2010																																																								2,000
shares issued and outstanding - 89,416,015 in 2011 and 87,238,301 in 2010																																																								89,000
accounts receivable from the sanofi-aventis group																																																									84,391,000	79,603,000	79,239,000	91,126,000	68,838,000	62,703,000	63,953,000	54,240,000	33,302,000	37,744,000	30,438,000	31,100,000
deferred revenue from sanofi-aventis, current portion																																																									19,561,000	19,506,000	19,335,000	19,126,000	17,784,000	17,523,000	21,580,000	21,553,000	21,390,000	19,017,000	18,855,000	18,855,000
deferred revenue from sanofi-aventis																																																									94,398,000	97,081,000	99,726,000	96,168,000	91,684,000	90,933,000	90,251,000	95,362,000	105,586,000	112,290,000	117,004,000	121,718,000
shares issued and outstanding - 2,182,036 in 2011 and 2010																																																									2,000
shares issued and outstanding - 88,548,041 in 2011 and 87,238,301 in 2010																																																									89,000
liabilities and stockholders’ equity
stockholders’ equity
preferred stock, .01 par value; 30,000,000 shares authorized; issued
and outstanding - none
class a stock, convertible, .001 par value: 40,000,000 shares authorized;
shares issued and outstanding - 2,182,036 in 2010 and 2,244,698 in 2009																																																										2,000		2,000
and outstanding - 87,238,301 in 2010 and 78,860,862 in 2009																																																										87,000
total stockholders’ equity																																																										527,815,000				396,762,000			418,852,000	436,933,000	450,997,000	460,603,000	151,397,000	179,336,000	196,689,000	216,624,000	62,473,000	83,767,000	102,323,000	114,002,000	136,381,000	165,060,000	185,784,000		178,873,000	190,130,000	204,106,000
total liabilities and stockholders’ equity																																																										1,089,432,000				741,202,000			670,038,000	825,891,000	851,225,000	930,876,000	573,096,000	597,858,000	601,431,000	585,090,000	355,186,000	378,332,000	402,089,000	423,501,000	419,275,000	446,948,000	470,292,000		472,685,000	488,174,000	506,178,000
restricted cash																																																											3,400,000	3,400,000	1,600,000	1,600,000	1,600,000	1,600,000	1,650,000	1,650,000	1,650,000	1,600,000	1,600,000	1,600,000	1,600,000	1,600,000
shares issued and outstanding - 2,181,831 in 2010 and 2,244,698 in 2009																																																											2,000
shares issued and outstanding - 80,042,523 in 2010 and 78,860,862 in 2009																																																											80,000
shares issued and outstanding - 79,923,216 in 2010 and 78,860,862 in 2009																																																												80,000
shares issued and outstanding - 2,211,698 in 2010 and 2,244,698 in 2009																																																													2,000
shares issued and outstanding - 79,690,055 in 2010 and 78,860,862 in 2009																																																													80,000
shares issued and outstanding - 2,244,698 in 2009 and 2,248,698 in 2008																																																														2,000
and outstanding - 78,860,862 in 2009 and 77,642,203 in 2008																																																														79,000
facility lease obligation																																																															62,571,000	62,925,000
outstanding-none
shares issued and outstanding - 2,246,698 in 2009 and 2,248,698 in 2008																																																															2,000	2,000
shares issued and outstanding - 78,243,286 in 2009 and 77,642,203 in 2008																																																															78,000
shares issued and outstanding - 77,921,038 in 2009 and 77,642,203 in 2008																																																																78,000
notes payable																																																																		117,503,000	118,653,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000
shares issued and outstanding - 2,248,698 in 2008 and 2,260,266 in 2007																																																																	2,000
and outstanding - 77,642,203 in 2008 and 76,592,218 in 2007																																																																	78,000
accounts receivable — other																																																																		4,462,000	2,400,000	1,860,000
deferred revenue — other, current portion																																																																		39,364,000	48,121,000	36,785,000
deferred revenue — other																																																																		56,012,000	59,306,000	62,601,000
preferred stock, .01 par value; 30,000,000 shares authorized; issued and outstanding-none
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding — 2,254,698 in 2008 and 2,260,266 in 2007																																																																		2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,257,698 in 2008 and 2,260,266 in 2007																																																																			2,000	2,000
deferred revenue, current portion																																																																					68,814,000	69,926,000	63,523,000	23,543,000	13,644,000	15,042,000	15,284,000	17,020,000	12,922,000	12,906,000	12,463,000	15,267,000	15,616,000	21,629,000	17,388,000	40,173,000	24,473,000	35,021,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,260,266 in 2007 and 2,270,353 in 2006																																																																					2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,270,353 in 2007 and 2006																																																																						2,000	2,000
inventory																																																																										2,128,000	3,254,000	2,904,000	2,837,000	3,746,000	3,087,000	3,229,000	4,266,000	10,850,000	9,098,000	9,006,000	7,698,000	10,342,000
preferred stock, .01 par value; 30,000,000 shares authorized; issued and outstanding — none
shares issued and outstanding — 2,270,353 in 2006 and 2,347,073 in 2005																																																																								2,000
shares issued and outstanding — 63,130,962 in 2006 and 54,092,268 in 2005																																																																								63,000
unearned compensation																																																																												-315,000	-811,000	-1,296,000	-1,783,000	-2,299,000	-1,989,000	-2,669,000	-3,363,000	-4,101,000	-1,873,000	-2,443,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,296,928 in 2006 and 2,347,073 in 2005																																																																									2,000	2,000
shares issued and outstanding - 2,307,561 in 2006 and 2,347,073 in 2005																																																																											2,000
shares issued and outstanding - 54,614,557 in 2006 and 54,092,268 in 2005																																																																											55,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding — 2,347,073 in 2005 and 2,358,373 in 2004																																																																												2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,351,873 in 2005 and 2,358,373 in 2004																																																																													2,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; 2,358,373 shares issued and outstanding in 2005 and 2004																																																																														2,000	2,000
53,763,234 shares issued and outstanding in 2005
53,502,004 shares issued and outstanding in 2004																																																																															54,000
restricted marketable securities																																																																																	5,548,000	5,518,000	10,977,000			5,319,000
loan payable to novartis pharma ag
2,358,373 shares issued and outstanding in 2004
2,365,873 shares issued and outstanding in 2003																																																																																	2,000
53,228,223 shares issued and outstanding in 2004
53,165,635 shares issued and outstanding in 2003																																																																																	53,000
class a stock, convertible, .001 par value; 40,000,000 shares authorized; 2,365,873 shares issued and outstanding in 2004 and 2003																																																																																		2,000	2,000
capital lease obligations, current portion
loan payable																																																																																					9,296,000	5,147,000

We provide you with 20 years of balance sheets for Regeneron Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Regeneron Pharmaceuticals. Explore the full financial landscape of Regeneron Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about Regeneron Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.